External Validation of the Lupus Multivariable Outcome Score for Systemic Lupus Erythematosus Trials.
Michal AbrahamowiczMaria Izabela AbrahamowiczPeter E LipskyPublished in: ACR open rheumatology (2022)
LuMOS 2.0 detected significantly greater treatment effects compared with the SRI-5 in the Illuminate trials. Additional validation of LuMOS 2.0 in trials of non-B cell-directed therapies will be necessary to document its universality as an outcome measure.